RMD 0.54% $37.28 resmed inc

News: ResMed profits rise

  1. lightbulb Created with Sketch. 1
    .


    ResMed’s Inc (ASX:RMD) profit rose nine per cent in its first quarter, buoyed by revenue growth and widening margins.


     


    However, that result missed analysts’ expectations.


     


    For the quarter ended September 30, ResMed posted a profit of $80.9 million, up from $71.3 million, in the previous corresponding period.


     


    Revenue rose 5 per cent to $357.7 million.


     


    ResMed develops products for the treatment of respiratory disorders, including flow generators and humidifiers.


     


    ResMed delivered a net profit of $331 million in fiscal 2013.

 
watchlist Created with Sketch. Add RMD (ASX) to my watchlist
(20min delay)
Last
$37.28
Change
0.200(0.54%)
Mkt cap ! $22.38B
Open High Low Value Volume
$37.50 $37.55 $37.15 $17.93M 480.5K

Buyers (Bids)

No. Vol. Price($)
1 3363 $37.27
 

Sellers (Offers)

Price($) Vol. No.
$37.30 1001 2
View Market Depth
Last trade - 16.10pm 22/11/2024 (20 minute delay) ?
RMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.